ESC Premium Access

Poster session 1 - PCI - Restenosis

Event: ESC CONGRESS 2017
Topic: Miscellaneous
Session type: Poster Session
Date: 26 August 2017

Congress Session

12 presentations in this session

Impact of the J-CTO score on long-term target lesion revascularization rate after native chronic total coronary occlusion angioplasty

Speaker: Doctor M. Abe (Kyoto, JP)

Contribution of post-stent irregular protrusion to in-stent neoatheroscrelosis after second-generation drug-eluting stent implantation. - Optical coherence tomography study-

Speaker: Doctor Y. Sanuki (Kitakyusyu, JP)

Impact of chronic kidney disease on stent strut coverage and neointimal tissue characteristics as assessed by optical coherence tomography

Speaker: Miss Y. Wang (Harbin, CN)

Predictors of target lesion revascularization after paclitaxel-coated balloon treatment of in-stent restenosis: a real-world single center registry.

Speaker: Doctor I. Bossi (Milano, IT)

Five-year outcomes after first- or second-generation drug-eluting stent implantation in all-comer patients undergoing percutaneous coronary intervention

Speaker: Doctor H. Yano (Tochigi, JP)

Clinical impact of immediate residual stenosis on clinical outcomes after deploying everolimus-eluting stent and biolimus-eluting stents: insights from a pooled analysis of RESET and NEXT trial.

Speaker: Mr H. Watanabe (Wakayama, JP)

Angiographic outcomes after the combined use of paclitaxel-coated balloon and excimer laser coronary angioplasty for drug-eluting stent in-stent restenosis.

Speaker: Doctor T. Higaki (Hiroshima, JP)

Qualitative and quantitative comparison of the neointima between bare-metal stents and sirolimus-eluting stents in the very late phase (>7 years); analysis by optimal frequency domain imaging

Speaker: Doctor H. Matsuda (Nagoya, JP)

Impact of drug-coated balloon in hemodialysis patients with in-stent-restenosis lesion

Speaker: Doctor N. Umemoto (Ichinomiya, JP)

Optical coherence tomography patterns of in-stent restenosis after drug-eluting stent implantation: a novel classification and its clinical significance

Speaker: Doctor W. Yamamoto (Takarazuka, JP)

12 speakers from this session

Doctor Mitsuru Abe

Kyoto Medical Center, National Hospital Organization, Kyoto (Japan)
0 follower

Doctor Yoshinori Sanuki

University of Occupational and Environmental Health, Japan, Kitakyusyu (Japan)
0 follower

Miss Yan Wang

The 2nd Affiliated Hospital of Harbin Medical University, Harbin (China)
0 follower

Doctor Irene Maria Bossi

ASST Grande Ospedale Metropolitano Niguarda, Milano (Italy)
0 follower

Doctor Hideki Yano

Ohtawara Redcross hospital, Tochigi (Japan)
0 follower

Mr Hiroki Watanabe

Japan Red Cross Society Wakayama Medical Center, Wakayama (Japan)
1 presentation
0 follower

Doctor Tadanao Higaki

Hiroshima City Hiroshima Citizens Hospiral, Hiroshima (Japan)
0 follower

Doctor Hiroaki Matsuda

Nagoya Heart Center, Nagoya (Japan)
0 follower

Doctor Norio Umemoto

Ichinomiya Municipal Hospital, Ichinomiya (Japan)
0 follower

Doctor Wataru Yamamoto

Higashi Takarazuka Satoh Hospital, Takarazuka (Japan)
0 follower

Doctor Roisin Colleran

Mater Private Network Dublin, Dublin (Ireland)
2 presentations
0 follower

Doctor Paul Morris

University of Sheffield, Department of Cardiovascular Science, Sheffield (United Kingdom of Great Britain & Northern Ireland)
1 presentation
0 follower

This platform is supported by

logo Novo Nordisk